您的位置: 首页 > 农业专利 > 详情页

ANTICORPS HUMAINS DIRIGÉS CONTRE L'ANTIGÈNE THOMSEN-NOUVEAU (TN)
专利权人:
Boehringer Ingelheim International GmbH
发明人:
申请号:
EP18786329.5
公开号:
EP3694889A1
申请日:
2018.10.12
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
The present invention provides compositions for the production of an antibody or functional fragment thereof directed against Thomsen-nouvelle (Tn) antigen (CD175) or a sialylated from thereof (sTn antigen, CD175s). The compositions disclosed herein include isolated antibody or functional fragments thereof that binds to Tn antigen or sTn antigen and polynucleotides encoding the heavy chain and/or a light chain variable domains of such antibody or functional fragment. The invention also provides methods of treating or preventing a disease, such as cancer or tumor formation, wherein the antibody or functional fragment includes a variable heavy chain domain and a variable light chain domain that has an amino acid sequence provided herein. The invention further provides a conjugate of an antibody or functional fragment thereof conjugated or recombinantly fused to a localizing agent, detectable agent or therapeutic agent, and methods of treating, preventing or diagnosing a disease in a subject in need thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充